Implementation Outcomes | Pharmacogenomics | Health coaching | Genetic testing | Digital health |
---|---|---|---|---|
Penetration/reach Overall 42% (21 of 50) | 94% (46 of 50) | 80% (40 of 50) average of 2+ sessions | 72% (36 of 50) | 64% (32 of 50) |
Acceptability (satisfaction, agreeable, palatable with it) what is acceptable | Positive: Patients and providers very positive; perceived as relevant to health Negative: Specialist resources needed to interpret results | Positive: Engaged patients holistically; interested patients reported value and potential to address health disparities Negative: Not all patients interested | Positive: Driver for patient participation in Humanwide Negative: Variants of uncertain significancea | Positive: Helped patients meet health goals; supported strong patient-provider relationships; quicker time to titrate meds Negative: Data and communication volume create burden for providers |
Feasibility (suitability for everyday use, can be carried out, resources/training/ Staff/self-efficacy) | Positive: Successfully executed Barriers: Primary care physicians cannot interpret results; requires specialist; data integration not standardized in EHR | Positive: Successfully executed Negative: Availability of resources | Positive: Successfully executed Negative: Requires specialist/ additional training to interpret results; data integration not standardized; specialist access limited | Positive: Integrated into regular patient-provider communication Negative: Technology challenges – Bluetooth pairing |
Sustainability/ Spread: Issues that facilitate or threaten spread/scale | Specialist resources needed to interpret results; insurance coverage/cost | Time (providers and patients) and skills needed (providers and staff) | Specialist resources needed to interpret results; insurance coverage/cost | Patient maintenance of digital health monitoring did not occur |